“…[1][2][3][4][5] As part of this endeavor, we conducted a search for antitumor compounds from a strain of Chaetomium globosum OUPS-T106B-6 that was originally isolated from the marine fish, Mugil cephalus, and reported six new cytotoxic metabolites designated as chaetomugilins A (1), B, C, D (2), E and F from the culture broth of this fungal strain. 6,7 These compounds are azaphilones and they have various bioactivities, including antimicrobial, nitric oxide inhibitory, gp120-CD4-binding inhibitory, monoamine oxidase inhibitory and platelet-derived growth factor-binding inhibitory activities. 7 An examination of a diseaseoriented panel of 39 human cancer cell lines (HCC panel) 8,9 suggested the possibility that the mode of action of chaetomugilins A (1), C and F might be different from that shown by any other anticancer drugs developed to date.…”